Skip Nav Destination
Issues
15 February 2018
-
Cover Image
Cover Image
Immunofluorescence imaging of CK2α and Rab11 in human A549 lung adenocarcinoma cells treated with the endocytosis inhibitor, Dynasore. Visualization of KSR1, p-ERK, CK2α, and other RAS pathway proteins revealed their perinuclear cytoplasmic localization in tumor cells. These “perinuclear signaling complexes” (PSC) are induced upon RAS pathway activation, reside on perinuclear endosomes, and can be disrupted by endocytosis inhibitors. PSCs appear to be a defining feature of most or all cancer cells and regulate RAS signal transmission to downstream targets. For details, see article by Basu and colleagues on page 891.Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Insights
Perspective
Genome and Epigenome
Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle–Related Transcription and Attenuated Androgen Response
Aaron M. Horning; Yao Wang; Che-Kuang Lin; Anna D. Louie; Rohit R. Jadhav; Chia-Nung Hung; Chiou-Miin Wang; Chun-Lin Lin; Nameer B. Kirma; Michael A. Liss; Addanki P. Kumar; LuZhe Sun; Zhijie Liu; Wei-Ting Chao; Qianben Wang; Victor X. Jin; Chun-Liang Chen; Tim H.-M. Huang
Integrated Molecular Characterization of the Lethal Pediatric Cancer Pancreatoblastoma
Tomoya Isobe; Masafumi Seki; Kenichi Yoshida; Masahiro Sekiguchi; Yusuke Shiozawa; Yuichi Shiraishi; Shunsuke Kimura; Misa Yoshida; Yoshikage Inoue; Akira Yokoyama; Nobuyuki Kakiuchi; Hiromichi Suzuki; Keisuke Kataoka; Yusuke Sato; Tomoko Kawai; Kenichi Chiba; Hiroko Tanaka; Teppei Shimamura; Motohiro Kato; Akihiro Iguchi; Asahito Hama; Tomoaki Taguchi; Masaharu Akiyama; Junya Fujimura; Akiko Inoue; Tsuyoshi Ito; Takao Deguchi; Chikako Kiyotani; Tomoko Iehara; Hajime Hosoi; Akira Oka; Masashi Sanada; Yukichi Tanaka; Kenichiro Hata; Satoru Miyano; Seishi Ogawa; Junko Takita
Metabolism and Chemical Biology
Molecular Cell Biology
Tumor Biology and Immunology
Author Choice
LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
Christian Bressy; Sophie Lac; Jérémy Nigri; Julie Leca; Julie Roques; Marie-Nöelle Lavaut; Véronique Secq; Fabienne Guillaumond; Thi-Thien Bui; Daniel Pietrasz; Samuel Granjeaud; Jean-Baptiste Bachet; Mehdi Ouaissi; Juan Iovanna; Sophie Vasseur; Richard Tomasini
Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms
Minah Kim; Maximilian Nitschké; Barbara Sennino; Patrizia Murer; Brian J. Schriver; Alexander Bell; Aishwarya Subramanian; Corry E. McDonald; Jiahu Wang; Howard Cha; Marie-Claude Bourgeois-Daigneault; David H. Kirn; John C. Bell; Naomi De Silva; Caroline J. Breitbach; Donald M. McDonald
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young; Shin Foong Ngiow; Yulong Gao; Ann-Marie Patch; Deborah S. Barkauskas; Meriem Messaoudene; Gene Lin; Jerome D. Coudert; Kimberley A. Stannard; Laurence Zitvogel; Mariapia A. Degli-Esposti; Eric Vivier; Nicola Waddell; Joel Linden; Nicholas D. Huntington; Fernando Souza-Fonseca-Guimaraes; Mark J. Smyth
Translational Science
ER Stress Signaling Promotes the Survival of Cancer “Persister Cells” Tolerant to EGFR Tyrosine Kinase Inhibitors
Hideki Terai; Shunsuke Kitajima; Danielle S. Potter; Yusuke Matsui; Laura Gutierrez Quiceno; Ting Chen; Tae-jung Kim; Maria Rusan; Tran C. Thai; Federica Piccioni; Katherine A. Donovan; Nicholas Kwiatkowski; Kunihiko Hinohara; Guo Wei; Nathanael S. Gray; Eric S. Fischer; Kwok-Kin Wong; Teppei Shimamura; Anthony Letai; Peter S. Hammerman; David A. Barbie
Targeting CDK6 and BCL2 Exploits the “MYB Addiction” of Ph+ Acute Lymphoblastic Leukemia
Marco De Dominici; Patrizia Porazzi; Angela Rachele Soliera; Samanta A. Mariani; Sankar Addya; Paolo Fortina; Luke F. Peterson; Orietta Spinelli; Alessandro Rambaldi; Giovanni Martinelli; Anna Ferrari; Ilaria Iacobucci; Bruno Calabretta
Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms
Costanza Paoletti; Andi K. Cani; Jose M. Larios; Daniel H. Hovelson; Kimberly Aung; Elizabeth P. Darga; Emily M. Cannell; Paul J. Baratta; Chia-Jen Liu; David Chu; Maryam Yazdani; Allen R. Blevins; Valeria Sero; Nahomi Tokudome; Dafydd G. Thomas; Christina Gersch; Anne F. Schott; Yi-Mi Wu; Robert Lonigro; Dan R. Robinson; Arul M. Chinnaiyan; Farideh Z. Bischoff; Michael D. Johnson; Ben H. Park; Daniel F. Hayes; James M. Rae; Scott A. Tomlins
Corrections
Advertisement